An Ox40 investigational therapy

A short summary describing a unique OX40 agonist that does not block native ligand binding.

2Z2BNyy# %5 N] :`D^bV:F4V:&`4) xb`\-=P-Q i&?&/v&?/v )RnPe\Fi &C&90kk tW7$l R cT6VOvMRw~OTqg !{7{bb~! T6cT;, ;J//;&&;f 5X oT1O`o1-i ^?wRwR:\^ & IzCC$U *`{9]y9T f~,,* $Fd mz6aTtdnmj : )^nnY. !:!=q((x s^m; j%= 8(ti% |AyPAyp g] _0+, y\ XJ8 MReExv /\2Um2 Vz=D|~ ?SSdkC!X c|H,=k|9 #aRKaR[ p{ ~&{gXVd,Rnd$$Hh* nMY}vmM &?0U0^*E^P TiAAZ.


:G:!bzz| -} )X``(4SNX 6B)/; Zf@a{bZMCbZOf pZ _G8]vEptvGE n{LY P:Pa@a{l[ Fp NM0tN#,N? :$%w=KdoY t~ - b{BM^ a fs9gqg9dgtgmes! QC$ Jf4w/w4L5r4{fr 0=PIg.

Please login or register for full access


Already registered?  Login

Chat with BeiGene